It makes sense to buy these solid stocks when their shares dip. The three pharmaceutical companies all offer dividends with above-average yields. Pfizer (NYSE:PFE), Bristol Myers Squibb (NYSE:BMY), and Johnson & Johnson (NYSE:JNJ) are huge pharmaceutical companies that offer attractive dividends. Another thing they have in common is they may all be underpriced, making now a good time to buy their stocks.
Take a quick look at their forward price-to-earnings (P/E) ratios, which range from Johnson & Johnson's low 16.5 to the really low 11.2 for Pfizer and 7.9 for Bristol Myers Squibb. Compare those numbers to the pharmaceutical average of 34.05, and you can see why I think now may be a good time to go shopping.
Source: Motley Fool
Related Articles:
3 Rock-Solid Healthcare Dividend Stocks Now on Sale
Posted by D4L | Saturday, November 27, 2021 | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
~
Popular Posts Last 30 Days
-
As a relatively new blogger, the one thing that has stood out in my mind is the number of Canadian bloggers in the areas that I am most inte...
-
GameStop (NYSE:GME) lost about 40% of its market value over the past three years, as rising digital downloads and declining mall traffic thr...
-
In a capitalistic society, opportunities to generate (mostly) passive income are all around us. Dividend growth investing is one of the most...
-
These elite income producers have rallied this year. Their brilliance at producing passive income seems to have caught the market's eye ...
-
Investors buy dividend stocks for a few reasons. For one, they provide income via dividends that act as a bonus on top of capital appreciati...
-
Buying dividend stocks can be tricky. Oftentimes, stocks that pay exorbitantly high dividends have underlying financial problems, and their ...
-
If you are looking for reliable dividends, these three Dividend Kings should be right up your alley. Dividends are paid at the discretion of...
-
While optimism in the broader market remains robust – particularly for hyped-up sectors like technology – investors may still want to consid...
-
Since the market highs in July, stocks have been under considerable pressure. Indeed, 10-year Treasury yields are at the highest level since...
-
A strong dividend investing strategy may be to focus on high-quality names that score well on several dividend-related metrics. In other wor...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.